Tevogen (TVGN) Other Non-Current Liabilities (2021 - 2026)

Tevogen Bio Holdings (TVGN) has 6 years of Other Non-Current Liabilities data on file, last reported at $648.0 in Q1 2026.

• Quarterly Other Non-Current Liabilities fell 99.12% year-over-year to $648.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $648.0 (down 99.12% YoY) and the FY2025 annual result came in at $26479.0, down 69.63% from the prior year.
• Other Non-Current Liabilities declined to $648.0 in Q1 2026, from $26479.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $14.0 million in Q2 2024 to a low of $648.0 in Q1 2026.
• A 5-year average of $1.7 million and a median of $60973.0 in 2024 frame the typical range for Other Non-Current Liabilities.
• The widest YoY moves for Other Non-Current Liabilities: up 95974.66% in 2025, down 99.32% in 2025.
• Tracing TVGN's Other Non-Current Liabilities over 5 years: stood at $7250.0 in 2022, then jumped by 300.0% to $29000.0 in 2023, then jumped by 200.62% to $87180.0 in 2024, then slumped by 69.63% to $26479.0 in 2025, then slumped by 97.55% to $648.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $648.0 (Q1 2026), $26479.0 (Q4 2025), and $14.0 million (Q3 2025), per Business Quant data.